Posts by: Margarida Azevedo

Margarida Azevedo

Margarida graduated with a BS in Health Sciences from the University of Lisbon and a MSc in Biotechnology from Instituto Superior Técnico (IST-UL). She worked as a molecular biologist research associate at a Cambridge UK-based biotech company that discovers and develops therapeutic, fully human monoclonal antibodies.

August 29, 2016

Less than Half of ICU Patients with Suspected Pneumonia Are Tested for Virus Infections, Dutch Researchers Find

Researchers investigated the clinical practices of testing for respiratory virus infections in intensive care unit (ICU) patients with suspected community-acquired pneumonia (CAP) or hospital-acquired pneumonia (HAP) and found that fewer than ... Read more

August 26, 2016

Rare Pneumonia Linked to Long-Term Use of Petroleum-Based Remedy

Patients commonly use petroleum-based over the counter remedies to alleviate symptoms of rhinitis. But such medicines carry risks of often under-appreciated side effects. In a recent report, researchers described a case in ... Read more

August 24, 2016August 24, 2016

Blood Marker for Bacterial Infections, Like Pneumonia, May Lead to Diagnostic Test

A team led by researchers at Imperial College London have identified two genes that are activated only in the presence of bacterial infection. This finding may lead to the development of a ... Read more

August 15, 2016August 15, 2016

Older Age and Wound Care Among Risk Factors for Drug-Resistant Pneumonia in Hospitals

Significant risk factors for pneumonia linked to drug-resistant pathogens in a healthcare setting — including in patients undergoing kidney dialysis, or hemodialysis — are advanced age, more severe pneumonia, and wound care, researchers reported. The study, which included as ... Read more

July 29, 2016

Study Pinpoints Molecule with Frontline Role in Immune Defenses Against Pneumonia

Researchers have discovered that a molecule with an apparently essential role in the body’s natural ability to fight pneumonia, although not quite the role they thought it would have. The discovery, ... Read more

July 27, 2016

Predictive Model for Pneumonia Risk After Cardiac Surgery Designed

Postoperative pneumonia is the most common infectious complication after open heart surgery, but according to recent research at the University of Michigan Medical School, an accurate predictive model for identifying the ... Read more

July 14, 2016July 14, 2016

Inhaled Corticosteroids Seen to Help COPD Patients Survive Pneumonia in Hospitals

Researchers examined the association between inhaled corticosteroid treatment and in-hospital mortality from pneumonia in patients with chronic obstructive pulmonary disease, and found that long-acting inhaled bronchodilators (IBD) therapy combined with corticosteroids ... Read more

June 24, 2016

Data on Community-Acquired Pneumonia Caused by Atypical Microorganisms Compiled

Researchers conducted a study to determine possible associations between atypical microorganisms that cause community-acquired pneumonia (CAP) and particular seasons, patient characteristics such as age and gender, and the presence of ... Read more

June 17, 2016June 17, 2016

Unnecessary Antibiotics Still Prescribed for Community-Acquired Pneumonia Due to Difficulties Identifying Resistant Strains

Researchers examined the true prevalence of methicillin (antibiotic)-resistant Staphylococcus aureus (MRSA) and methicillin-susceptible S. aureus (MSSA) in the context of community-acquired pneumonia (CAP) — and how the current guidelines affect clinical and antibiotic-selection decisions. ... Read more

June 16, 2016June 16, 2016

Meridian’s Rapid and Easy Test for M. Pneumoniae Now Available in the US

Meridian Bioscience announced that the U.S. Food and Drug Administration (FDA) has cleared its newly updated and simplified molecular diagnostic test for Mycoplasma pneumoniae, the cause of an infectious if mild form of ... Read more